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ing author. +90 262 3037
ess: tubaliman@kou.edSummary Pulmonary blastoma is a rare malignant lung tumor with a poor
prognosis. It is composed of immature mesenchymal and epithelial components that
resemble fetal lung tissue. We aimed to share our treatment results in biphasic
pulmonary blastoma.
In Ataturk Chest Disease and Thoracic Surgery Center, five patients with biphasic
pulmonary blastoma (four men, one woman, aged between 27 and 61—mean 39.4)
were treated between 1987 and 2000 (0.3% of operated NSCC). Hemoptysis, cough,
chest pain and dyspnea were the symptoms. Anemia and high erythrocyte
sedimentation rate were determined in two patients. Radiological examinations
revealed a mass in four patients and massive pleural effusion in one. None of the
patients were diagnosed preoperatively and hence all patients underwent
exploratory thoracotomy. Three lobectomy, one pneumonectomy and one wedge
resection were performed.
Histopathological examinations revealed biphasic pulmonary blastoma in all the
patients. Pathological stagings were as follows: 1 patient in T1N0M0 and 1 patient in
T2N0M0 (198 and 112 months survival, respectively), three patients in T2N1M0
(9,10,17 months survival). In follow up period, prostate carcinoma and rectum
carcinoma were detected as second primary tumors in the patient in stage
T2N0M0.
In patients who have small size tumors without nodal involvement, long-term
survival can be obtained with radical surgery; even in biphasic pulmonary blastomas.Elsevier Ltd. All rights reserved.
407; fax: +90 262 3038 003.
u.tr (S.T. Liman).
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prognosis.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Pulmonary blastomas (PB) are malignant tumors of
uncertain histogenesis that histologically resembles
the developing in early fetal life. It was hypote-
sized that it originated from immature pulmonary
‘‘blastema’’ pleuropotential tissue capable of
differentiating into both mesenchymal and epithe-
lial portions of the peripheral lungs.1 There are
seen very rarely, 0.5% of all primary lung tumors.2
PB are divided into three sub-groups: biphasic
pulmonary blastoma (PB), well differentiated fetal
adenocarcinoma (WDFA) and pleuropulmonary blas-
toma (PPB). WDFA are tumors which contains
epithelial malignant component without mesench-
ymal malignancy. PPB indicates tumors with me-
senchymal malignancy but without epithelial
malignant component. PB are chacterized by a
dual or biphasic immature cellular component both
are malignant (epithelial and mesenchymal). Here
we presented five biphasic pulmonary blastoma and
the results of our treatment.Patients
Between 1987 and 2000, we operated 1411 cases
with NSCLC in Ataturk Chest Disease and Thoracic
Surgery Center. Five of them were biphasic PB
(0.3%).
There was a male predominance in the patients
with PB. Their ages ranged between 27 and 61
years. Three of them were smokers. Patients’
characteristics were summarized in Table 1.
The most frequently seen complaints were
cough, hemoptysis and chest pain. Anemia and
high erythrocyte sedimentation rates were de-
tected in two patients with big tumors.
Chest X-ray and thorax tomography were per-
formed in all patients (Figs. 1 and 2). In four
patients, radiological examinations revealed soli-
tary pulmonary mass. In one patient, first examina-
tions showed massive pleural effusion and
empyema was detected via thoracentesis. After
chest tube drainage, solitary big pulmonary mass
was observed in his chest X-ray.
Tumors were located in lower lobes in three
patients, in upper lobe in one and in middle lobe in
one patient.Bronchoscopy was performed in all patients and
endobronchial tumor was observed in three. But
bronchoscopic biopsy was not diagnostic in those
patients.
Diagnosis could not be obtained in all of the
patients preoperatively and they all underwent
thoracotomy. Wedge resection was performed in
one patient, lobectomy in three and pneumonect-
omy in one patient. Wedge resection was per-
formed since frozen section examination could not
be performed. He was advised to have a second
operation, but he refused. When recurrences was
detected in his 3 months follow up after surgery, he
accepted the operation and lobectomy was per-
formed.
Staging was defined in accordance with the lung
cancer staging system. Survivals were measured
from the time of diagnosis.Results
All patients were diagnosed as biphasic pulmonary
blastoma after histopathological examination of
the specimens. Lymph node involvement were
detected in three cases with larger tumors
(Table 1). There were one patient in T1N0M0,
one pateint in T2N0M0 and three patients in
T2N1M0.
Bronchopleural fistula was occured in the
patient who underwent pnemonectomy (T2N1M0).
Thoracomyoplasty was performed as a second
operation in that case. In his follow up period
local recurrence was developed. Esophageal and
cardiac involvement were detected. He had
4000 rad radiotherapy. But treatment was unsuc-
cessful and he died in his 9th month of follow up
period.
In two patients (T2N1M0) systemic metastasis
were detected in follow up and chemotherapy was
given. But there was no response to chemotherapy
and they died. Survivals of those patients were
were 10, 17 months.
Two patients with tumors 3 cm (T1N0M0) and
3.6 cm (T2N0M0) in size had long-term survivals,
198 and 112, respectively. First patient is still
alive. Two different carcinoma were occurred in
the second patient while follow up. He was
given treatment for prostate carcinoma and
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Figure 2 Posteroanterior and CT scan appearance of a
solitary mass in the right lower lobe.
Figure 1 Posteroanterior and CT scan appearance of
lobulated circumscribed large mass with heterogenous
enhancement in the middle lobe of the right lung.
Pulmonary blastoma 1177rectal carcinoma and he died because of the
complications of chemotherapy for rectal carcino-
ma in his 112th months.Conclusion
Pulmonary blastomas (PB) are rarely seen tumors.
They are composed of both mesenchymal and
epithelial components which resemble fetal lung
tissue morphologically with a frequency of only
0.5% of all primary lung tumors.2 It has been shown
that the tumor arises from the endodermal tissue or
that it originates in pleuropotential stem cells.3,4
Some authors consider pulmonary blastoma to
represent a variant of carcinosarcoma.5 There were
three types of PB. Biphasic PB have two malignant
components; epithelial and mesenchymal. The
prognosis of biphasic blastoma is much worse than
the others.The etiology and predisposing factors are not still
fully understood. In the literature, there is strong
evidence showing the correlation between cigar-
ette smoking and PB.6,7
They may occur at all ages but predominantly
common in adults (the peak incidence in the fourth
decade of life). There is a male predominance.2
When compared to the operated nonsmall cell
lung carcinomas, PB are rare, large and sympto-
matic tumors which affect younger age groups and
have poor prognosis.8 Approximately 60% of the
patients are symptomatic.9–11 All of our patients
were symptomatic. We detected anemia in two
patients who had larger tumors and nodal involve-
ments.
Biphasic blastomas are usually located in the
periphery of the lung.12 Only 25% exhibit endo-
bronchial growth.13,14 Three of our patients had
endobronchial tumor but bronchoscopic biopsies
ARTICLE IN PRESS
S.T. Liman et al.1178were not diagnostic. Pleural effusions occur in a
minority of cases. It sometimes may be infected
causing empyema like in one of our patients.
Considerable immunoreactivity for alpha-feto-
protein (AFP) was reported in the literature.15,16 It
was pointed out that the epithelial cells of PB might
occasionally de-differentiate into cells functionally
resembling fetal hepatic, foregut and yolk sac cells
expressing AFP.15 Unfortunately AFP levels were not
measured in our patients.
In radiological examinations, PB manifest as a
solitary pulmonary nodule or mass with a smooth
margin because of the desmoplastic change sur-
rounding the mass. Generally, the tumor has
massive necrosis.17 The tumor rarely appear to be
cavitated, calcified or multiple.
Despite bronchoscopy, mediastinoscopy, thoraco-
scopy, percutaneous and transbronchial biopsies,
PB cannot be diagnosed preoperatively due to the
lack of cellular material and extensive necrosis of
the lesions.18 We also could not diagnose pulmonary
blastoma preoperatively.
The best treatment of pulmonary blastoma is
surgery in the early stages of the disease. Adjunc-
tive therapy is still controversial because of lack of
data. Rare cases, which have good responds to
chemotherapy and radiotherapy, have been re-
ported in the literature whereas in the majority of
cases recurrences are seen.19–21 Cutler et al.
treated and reviewed the chemotherapy literature
for PB and recommended cisplatin and etoposide
treatment as effective regimes.15 Neoadjuvant
chemotherapy for downstaging advanced tumors
can be used before surgical resections.7 Recur-
rences are mostly seen with the incidence of 43%,
1–11 months after surgery.18 Recurrences most
commonly occur in the brain, mediastinum, pleura,
liver, diaphragm, heart and soft tissues of extre-
mities.18
Nodal involvement is almost always associated
with the tumor size and also poor prognosis in
biphasic PB.6
Based on our limited experience, resection of
small tumors, which do not have any lymph node
involvement, can provide better survival without
any additional treatment. Wedge resection should
not be performed in PB. In one of our patient, there
was a recurrence due to the inadequate surgical
procedure (wedge resection). That patient under-
went second operation, he did not have any nodal
involvement and he has the best survival time in
this small serie. In our cases adjuvant chemothera-
pies were not effective.
Finally, in the patients with small size tumors,
which do not have nodal involvement, long-term
survival can be obtained with surgery even if it isbiphasic pulmonary blastoma. According to our
limited experiences, N1 nodal involvement shows
very poor prognosis even tumor is resected com-
pletely. Unfortunately, we still do not know the
efficiency of the adjuvant chemotherapy and radio-
therapy treatment. Multi-institutional treatment
protocols in a sufficient number of patients should
be performed.References
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